Lmwx 40mg 0.4ml Injection

Lmwx 40mg 0.4ml Injection is an anticoagulant medication containing Enoxaparin (40mg), designed for the prevention and treatment of harmful blood clots. This low molecular weight heparin (LMWH) works by inhibiting clotting factors, thereby restricting the formation of new clots and preventing existing ones from enlarging.

The injection is indicated for a range of clinical applications, including the prevention and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also utilized in the management of acute coronary syndrome, encompassing unstable angina and myocardial infarction, and for preventing blood clots in patients undergoing surgery, such as hip or knee replacement procedures. Additionally, it is beneficial for individuals with severely restricted mobility during acute illness and for preventing clot formation in dialysis machine tubes.

Lmwx 40mg 0.4ml Injection is typically administered via subcutaneous injection, usually in the abdomen or thigh, and in specific clinical settings, it may be given intravenously. It requires a prescription for dispensing and is classified under Schedule H. For optimal efficacy, the product should be stored at room temperature, typically below 30°C (86°F), protected from light and moisture, and must not be frozen.

Key Features : 

Active ingredient Enoxaparin (40mg) functions as an anticoagulant to prevent and treat blood clots.
Licensed indications include prophylaxis and treatment of deep vein thrombosis, pulmonary embolism, acute coronary syndrome, and post-surgical clot prevention.
Store at room temperature below 30°C, protected from light and moisture; do not freeze.
Requires a prescription and is categorized under Schedule H.